NEWS

When Nucleic Acid Therapeutics Meet the Blood–Brain Barrier: Exosomes as the Breakthrough Solution
The Investment Thesis: CNS RNA Medicines Need a Delivery BreakthroughNucleic acid therapeutics have reached a critical inflection point in the treatment of central nervous system (CNS) diseases. Ac...
We’re recruiting volunteers for IIT on RP-ILD
Respected Colleagues,The Department of Respiratory Medicine at the First Affiliated Hospital of Guangzhou Medical University is conducting a clinical study titled "Safety and Efficacy Study of...
The Beijing Autumn Forum for New Drug Founders concluded successfully, and new drug founders discussed the vitality of innovation.
In October, 2024，the New Drug Founders' Beijing Autumn Forum successfully concluded. Held on October 24th and co-hosted by the International Center For Science & Technology Innovation, the...
Dr. Tinghe Wu, Academic Founder and CEO of P.S.K Biosciences, Invited to Participate in the BIOCHINA2024(EBC).
On March 16, 2024, the BIOCHINA2024/EBC successfully concluded at the Suzhou International Expo Center. With the theme ‘Collaboration Accelerates Innovation,’ the conference highlighted the develop...
P.S.K.Biosciences Website launch
After careful planning and preparation, P.S.K.Biosciences corporate website officially launched. Through this website, you will be able to get the company's latest product information and news ...
Exosomes, a new generation of drug delivery carriers.
Exosomes are small extracellular vesicles (30-150 nm) secreted by various cell types, functioning as key mediators of intercellular communication by transporting bioactive molecules such as protein...